Please login to the form below

Not currently logged in
Email:
Password:

Radicava

This page shows the latest Radicava news and features for those working in and with pharma, biotech and healthcare.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn

The Parkinson's disease candidates will extend Mitsubishi's CNS portfolio in the US, which will see a major launch next month when the Japanese company introduces Radicava (edaravone), a new

Latest news

  • FDA clears new ALS drug Radicava ahead of schedule FDA clears new ALS drug Radicava ahead of schedule

    FDA clears new ALS drug Radicava ahead of schedule. MT Pharma’s medicine will soon offer US patients an alternative to Sanofi’s Rilutek. ... Patients with the chronic neurodegenerative disease amyotrophic lateral sclerosis (ALS) have a new treatment

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics